HHS Drug Forum Line-Up Covers Patients, Consumers, Rx Makers, Medicaid, Plans

The line-up for the day-long HHS Pharmaceutical Forum on Friday (Nov. 20) includes advocates for patients and consumers; two brand-drug company executives; a generic-drug representative; representatives for a health plan, a pharmacy benefit manager and a payer; a Florida Medicaid official; researchers; and former head of both FDA and CMS Mark McClellan. HHS put the forum together to get ideas for dealing with increasingly expensive drugs, and much of the discussion on Friday is expected to be about basing drug...